XEMRYVOS
Live / Allowed — Published for opposition (as of 25 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99548422
- Mark type
- Word mark
- Filed
- 15 Dec 2025
- Published for opposition
- 25 Aug 2026
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jul 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 23 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jul 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 16 Apr 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 16 Apr 2026 — LETTER OF SUSPENSION E-MAILED
- 16 Apr 2026 — SUSPENSION LETTER WRITTEN
- 16 Apr 2026 — ASSIGNED TO EXAMINER